Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraise

The high-profile startup, co-founded by CAR-T innovator Carl June, will use the funds to bring an autoimmune disease treatment into proof-of-concept studies. 

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks